By Pete Brush ( August 6, 2014, 1:41 PM EDT) -- Pfizer Inc. agreed Wednesday to dole out $35 million to states across the country to settle claims by attorneys general that Wyeth Pharmaceuticals Inc. pushed Rapamune, an immunosuppressive drug used to prevent organ rejection after kidney transplants, for off-label uses including liver, heart and lung transplants....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.